Baxion
Screening
Tags
Alerts
Theme
Agios Pharmaceuticals, Inc.
AGIO
·
NASDAQ
·
$28.33
Share Price as of 11/2
·
$2B
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
07/30/26
10-Q
Q1 ended 03/31/26
04/29/26
10-K
FY 2025
02/12/26
10-Q
Q3 ended 09/30/25
10/30/25
10-Q
Q2 ended 06/30/25
07/31/25
Disclosures
Filter
8-K
Current report
07/30/26
8-K
Current report
06/18/26
8-K
Current report
04/29/26
8-K
Current report
02/12/26
8-K
Current report
01/12/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
06/18/26
S-3ASR
Automatic shelf registration
02/12/26
S-8
Registration of securities for employees
06/18/25
S-8
Registration of securities for employees
03/05/25
S-8
Registration of securities for employees
06/13/23
Proxies
Filter
DEF 14A
Definitive proxy
04/24/26
DEFA14A
Additional proxy materials
04/24/26
DEF 14A
Definitive proxy
04/25/25
DEFA14A
Additional proxy materials
04/25/25
DEF 14A
Definitive proxy
04/26/24
Ownership
Filter
Form 4
Insider transaction
10/28/26
144
Proposed sale of securities
10/26/26
Form 4
Insider transaction
10/23/26
144
Proposed sale of securities
10/22/26
144
Proposed sale of securities
10/21/26
Other
Filter
ARS
Annual report to shareholders
04/24/26
ARS
Annual report to shareholders
04/25/25
UPLOAD
Letter from the SEC
06/24/24
CORRESP
Correspondence with the SEC
06/11/24
UPLOAD
Letter from the SEC
05/30/24
Latest Filings
Filter
10-Q
Q2 ended 06/30/26
07/30/26
8-K
Current report
07/30/26
8-K
Current report
06/18/26
S-8
Registration of securities for employees
06/18/26
10-Q
Q1 ended 03/31/26
04/29/26
Ownership
Filter
Form 4
Insider transaction
10/28/26
144
Proposed sale of securities
10/26/26
Form 4
Insider transaction
10/23/26
144
Proposed sale of securities
10/22/26
144
Proposed sale of securities
10/21/26